opioids Archives

Pharmalot By Ed Silverman

Judge reverses $4.5 billion Purdue Pharma bankruptcy settlement

Health By Troy Farah

How much naloxone is needed to reverse an opioid overdose? New high-dose treatments are raising questions

Politics By Nicholas Florko

Califf sails through confirmation hearing for FDA job, despite tensions over opioids

Pharmalot By Ed Silverman

AbbVie unit to pay $200 million to resolve closely watched opioid lawsuit in New York

Health By John Seewer — Associated Press

Jury holds pharmacies responsible for role in opioid crisis

Health By Andrew Joseph

Her husband died by suicide. She sued his pain doctors — a rare challenge over an opioid dose reduction

Pharmalot By Ed Silverman

Can local governments convince the courts that opioid makers and wholesalers caused a public nuisance?

Pharmalot By Ed Silverman

Company that sold overdose antidote to pay $12.7 million to settle charges of fraudulent scheme

Pharmalot By Ed Silverman

Oklahoma court overturns $465 million opioid verdict against Johnson & Johnson

Pharmalot By Ed Silverman

In a first, a California judge rules drug makers are not liable for the opioid crisis

Pharmalot By Ed Silverman

The Purdue bankruptcy plan was approved to distribute billions. Where is the money?

First Opinion By Matthew Stefanko, Brea Perry and Anne Krendl

A new index measures the extent and depth of addiction stigma

Politics By Nicholas Florko

Is Robert Califf a savvy choice to helm the FDA — again?

Health By Evan Allen — Boston Globe

Prosecutors allege two individuals preyed on those searching for addiction recovery help

Pharmalot By Ed Silverman

As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group

First Opinion By William F. Haning, III

Overdose prevention sites can save lives and promote recovery. We must be willing to try them

First Opinion By Haider J. Warraich

Start now to prevent the next Purdue Pharma debacle

Pharmalot By Ed Silverman

The Purdue bankruptcy plan was approved. Will it get derailed by appeals?

Health By John Seewer and Geoff Mulvihill — Associated Press

Purdue bankruptcy settlement leaves families angry, conflicted

Pharmalot By Ed Silverman

Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers

Pharmalot By Ed Silverman

David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity

First Opinion By Sika Yeboah-Sampong and Gail D'Onofrio

Medically, legally, and morally, emergency departments cannot ignore addiction care

First Opinion By William Cooke

Harm-reduction programs acknowledge the difference between ‘do no harm’ and ‘protect from harm’

First Opinion By Dick Durbin

With the tobacco settlement, the U.S. missed its moment to fortify public health. We can’t make that mistake with the opioid settlement

First Opinion By Nora D. Volkow

Most Read

States: Sackler family members abusing bankruptcy process

U.S. overdose deaths topped 100,000 in one year, officials say

FDA’s kratom ban would harm the public and damage the agency’s credibility

People recover from addiction. They also go on to do good things

A new book traces the roots of the opioid crisis through the secretive Sackler family

The history of OxyContin, told through unsealed Purdue documents

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

Revamped OxyContin was supposed to reduce abuse, but has it?

All Coverage

Judge reverses $4.5 billion Purdue Pharma bankruptcy settlement

How much naloxone is needed to reverse an opioid overdose? New high-dose treatments are raising questions

Califf sails through confirmation hearing for FDA job, despite tensions over opioids

AbbVie unit to pay $200 million to resolve closely watched opioid lawsuit in New York

Jury holds pharmacies responsible for role in opioid crisis

Her husband died by suicide. She sued his pain doctors — a rare challenge over an opioid dose reduction

Can local governments convince the courts that opioid makers and wholesalers caused a public nuisance?

Company that sold overdose antidote to pay $12.7 million to settle charges of fraudulent scheme

Oklahoma court overturns $465 million opioid verdict against Johnson & Johnson

In a first, a California judge rules drug makers are not liable for the opioid crisis

The Purdue bankruptcy plan was approved to distribute billions. Where is the money?

A new index measures the extent and depth of addiction stigma

Is Robert Califf a savvy choice to helm the FDA — again?

Prosecutors allege two individuals preyed on those searching for addiction recovery help

As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group

Overdose prevention sites can save lives and promote recovery. We must be willing to try them

Start now to prevent the next Purdue Pharma debacle

The Purdue bankruptcy plan was approved. Will it get derailed by appeals?

Purdue bankruptcy settlement leaves families angry, conflicted

Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers

David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity

Medically, legally, and morally, emergency departments cannot ignore addiction care

Harm-reduction programs acknowledge the difference between ‘do no harm’ and ‘protect from harm’

With the tobacco settlement, the U.S. missed its moment to fortify public health. We can’t make that mistake with the opioid settlement

Punishing drug use heightens the stigma of addiction